(Q39445066)

12 September 2017

title

Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer (English)

1 reference

12 September 2017

1 reference

Eva Kopansky

1

1 reference

12 September 2017

Yosi Shamay

series ordinal

2

1 reference

12 September 2017

Ayelet David

series ordinal

3

1 reference

12 September 2017

publication date

10 November 2011

1 reference

Journal of Drug Targeting

12 September 2017

published in

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

933-943

1 reference

Ligand-targeted therapeutics in anticancer therapy

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Differential expression of epidermal growth factor-related proteins in human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

The epidermal growth factor (EGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

HPMA copolymers: origins, early developments, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Biological modulation by lectins and their ligands in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Diet, fecal water, and colon cancer--development of a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2011.632011

10.3109/1061186X.2011.632011

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference